Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN Prodrug |
ATC: | P01BE01 |
UNII: | 9RMU91N5K2 |
InChI Key | BLUAFEHZUWYNDE-DKGJTOOQSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C15H22O5 |
Molecular Weight | 282.34 |
AlogP | 2.39 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 0.0 |
Polar Surface Area | 53.99 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 20.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2B
Cytochrome P450 2B6
|
600 | 8400-12100 | - | 4600 | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
5900 | 50000-50000 | - | 25000 | - | |
Enzyme
Hydrolase
|
- | - | - | - | 2 | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 2
|
30000 | - | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 105 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Schizophrenia | 3 | D012559 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 63968-64-9 |
ChEMBL | CHEMBL567597 |
FDA SRS | 9RMU91N5K2 |
Guide to Pharmacology | 9954 |
PubChem | 68827 |
SureChEMBL | SCHEMBL60303 |
ZINC | ZINC000100014791 |